Gapping up
In reaction to earnings/guidance:
- ATKR +18.2%, CTLT +5.1%, HAE +4.3%, WAT +4.1%, PINC +3.6%, UPS +3.5%, HCA +3%, HLIT +2.9%, MCK +2.9%, OMCL +2.8%, SKY +2.7%, EMR +2.7%, LII +2.4%, MPC +2.2%, MDC +2.1%, XOM +2.1%, MPLX +1.8%, ENTG +1.4%, COP +1.4%, SIRI +1.4%, FN +1.3%, KRC +1.3%, ETN +1.2%, PCH +1%
Other news:
- MBRX +46.8% (announces achievement of 100% survival in osteosarcoma lung metastases animal model)
- TLSA +42.4% (reports positive data from the clinical study of nasal administration with Foralumab in Brazil)
- HOL +36.4% (Holicity: Astra to become the first publicly traded space launch company on NASDAQ via merger with Holicity)
- PHGE +29.6% (announces "positive" results of a first-in-human Phase 1a pharmacokinetic study of BX002)
- PRTA +29.1% (to advance birtamimab into confirmatory Phase 3 AFFIRM-AL study)
- TVTX +20.7% (announces that the Company's ongoing pivotal Phase 3 DUPLEX Study of sparsentan in focal segmental glomerulosclerosis achieved its pre-specified interim FSGS partial remission of proteinuria endpoint after 36 weeks of treatment)
- ACAC +16.5% (enters into merger agreement with PLAYSTUDIOS)
- TTI +16.2% (regains NYSE compliance with minimum average closing price requirements)
- GSM +15.6% (extends momentum)
- LPG +12.6% (to commence tender offer to repurchase up to $100 million of its common shares)
- SPCE +11.2% (SpaceX announces first mission to space with all-civilian crew, according to NBC News)
- VRNA +10.8% (reports Phase 2 results with pMDI formulation of Ensifentrine in COPD)
- MBIO +9.7% (provides updates on MB-107 and MB-207, its lentiviral gene therapies for the treatment of X-linked severe combined immunodeficiency, also known as bubble boy disease)
- WBAI +8.9% (enters agreements to acquire two bitcoin mining machines)
- AI +8.2% (AI, RDS.A, BKR, and MSFT launch Open AI Energy Initiative)
- WTTR +7.4% (guides Q4 revs above consensus; announces commencement of two projects; announces $3 mln investment in Deep Imaging Tech)
- EYPT +6.7% (prices offering of 9.1 mln shares of common stock at $11.00 per share)
- MWK +6.2% (acquires Healing Solutions, an online seller of essential oils; raises guidance to include the acquisition)
- SHEN +5.4% (announces $1.95 bln cash sales price for its wireless assets and operations to T-Mobile (TMUS))
- KOPN +3.8% (Kopin and HMDmd have signed an agreement with a medical technology company to design a precision head-worn display system)
- DQ +3.5% (provides updates on the status of the proposed initial public offering (STAR Market IPO) and listing of the shares of its subsidiary Xinjiang Daqo New Energy)
- BDTX +3.3% (files for $150 mln mixed securities shelf offering)
- HOLX +3.1% (collaboration with Google Cloud)
- XOM +2.2% (creates new low-carbon solutions business)
- F +2% (invests $1 bln to modernize, expand South African manufacturing for all-new Ranger)
- CERC +1.9% (announces that the U.S. Food and Drug Administration has granted Fast Track designation to CERC-803 for the treatment of Leukocyte Adhesion Deficiency Type II)
- CLBK +1.7% (authorizes 5 mln share repurchase program)
Analyst comments:
- VIPS +4.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- PANW +3.5% (upgraded to Outperform from Neutral at Credit Suisse)
- DELL +3.2% (upgraded to Buy from Neutral at Goldman)
- RDY +3% (upgraded to Overweight from Equal Weight at Barclays)
- OMCL +2.8% (upgraded to Overweight from Neutral at Piper Sandler)